Home > Healthcare > Pharmaceuticals > Finished Drug Form > U.S. Medical Marijuana Market
U.S. Medical Marijuana Market Size
- Report ID: GMI2890
- Published Date: Oct 2022
- Report Format: PDF
U.S. Medical Marijuana Market Size
U.S. Medical Marijuana Market size was worth more than USD 9 billion in 2021 and is anticipated to exhibit 10% CAGR between 2022 to 2030.
Increasing awareness regarding the health benefits of cannabis and cannabidiol (CBD) to treat various clinical conditions will boost the market landscape. CBD is a non-impairing compound found in marijuana that does not induce euphoria. It has multiple health benefits including pain management, appetite enhancement, reduced eye pressure, and many more.
The United States Food and Drug Administration (FDA) encourages new drug development efforts and is steadily authorizing medicines containing therapeutic compounds derived from cannabis. The product could help treat patients of age one year and above with seizures caused by tuberous sclerosis complex (TSC).
| Report Attribute | Details |
|---|---|
| Base Year: | 2021 |
| U.S. Medical Marijuana Market Size in 2021: | 9 Billion (USD) |
| Forecast Period: | 2022 to 2030 |
| Forecast Period 2022 to 2030 CAGR: | 10% |
| 2030 Value Projection: | 2 Billion (USD) |
| Historical Data for: | 2017 to 2021 |
| No. of Pages: | 225 |
| Tables, Charts & Figures: | 413 |
| Segments covered: | Application, Route of Administration, Distribution Channel, and Zones |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
Strict federal laws against cannabis production in some states may impede industry across the U.S. As per federal law, cannabis remains illegal and banks in the U.S. are under strict compliance with the government to avoid taking funds from marijuana businesses. The lack of a policy framework pertaining to the production and sale of marijuana in many parts of the country may hinder the U.S. medical marijuana market forecasts.
Frequently Asked Questions (FAQ) :
U.S. Medical Marijuana Market Scope
